Table 1.

Nrf2 Immunolabeling in the RPE of Unaffected and Early AMD donors.

Donor	Age (Yrs)	Gender	D-E (Hrs)	Nrf2 labeling
				Macula		Periphery
				Nucleus	Cytoplasm	Nucleus	Cytoplasm
AMD
1	60	M	28	Yes	Yes	No	No
2	61	M	20	Yes	Yes	No	No
3	68	F	20	Yes	Yes	No	No
4	69	F	19	Yes	Yes	No	No
5	83	F	12	Yes	Yes	No	No
6	83	F	14	No	Yes	No	No
7	84	M	44	Yes	Yes	No	No
8	87	F	70	Yes	Yes	No	No
9	87	M	24	Yes	Yes	No	No
10	90	M	20	Yes	Yes	No	No
11	94	F	8	Yes	Yes	No	No
12	96	M	5	No	Yes	No	No
Unaffected
1	8 months	M	63	No	No	No	No
2	37	M	23	No	No	No	No
3	50	F	3	No	No	No	No
4	64	M	65	No	No	No	No
5	67	F	67	No	No	No	No
6	69	M	46	No	Yes	No	No
7	82	F	45	No	No	No	No
8	84	F	75	Yes	Yes	No	No

M: male; F: female; D-E: death to enucleation time.